Yonhap Infomax NewsOct 30
Lotte Biologics and SK Pharmteco have signed a strategic LOI to jointly provide ADC-specialized CDMO services, aiming to expand their presence in the global antibody-drug conjugate market.
#YonhapInfomax #LotteBiologics #SKPharmteco #ADC #CDMO #GlobalMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88171
Lotte Biologics Signs Strategic LOI with SK Pharmteco to Target Global ADC Market

Lotte Biologics and SK Pharmteco have signed a strategic LOI to jointly provide ADC-specialized CDMO services, aiming to expand their presence in the global antibody-drug conjugate market.

Yonhap Infomax